Home > Insider Trading > Filing (0001140361-11-030050)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
874716	Idexx Laboratories Inc	IDXX	In Vitro & In Vivo Diagnostic Substances (2835)	010393723

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1184151	R Conan Deady	One Idexx Drive Westbrook ME 04092	Corp Vp, General Counsel & Sec	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2011-05-25	9,764	$28.66	29,111	No	4	M	Direct
Common Stock	Acquisiton	2011-05-25	2,368	$38.34	31,479	No	4	M	Direct
Common Stock	Acquisiton	2011-05-25	218	$41.94	31,697	No	4	M	Direct
Common Stock	Acquisiton	2011-05-25	105	$41.94	31,802	No	4	M	Direct
Common Stock	Acquisiton	2011-05-25	7,545	$34.37	39,347	No	4	M	Direct
Common Stock	Disposition	2011-05-25	20,000	$77.26	19,347	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Non-Qualified Stock Option (right to buy)	Disposition	2011-05-25	9,764	$0.00	9,764	$28.66
Common Stock	Incentive Stock Option (right to buy)	Disposition	2011-05-25	2,368	$0.00	2,368	$38.34
Common Stock	Incentive Stock Option (right to buy)	Disposition	2011-05-25	218	$0.00	218	$41.94
Common Stock	Non-Qualified Stock Option (right to buy)	Disposition	2011-05-25	105	$0.00	105	$41.94
Common Stock	Non-Qualified Stock Option (right to buy)	Disposition	2011-05-25	7,545	$0.00	7,545	$34.37

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2015-02-02	No	4	M	Direct
0	2013-02-13	No	4	M	Direct
2,384	2014-02-13	No	4	M	Direct
17,733	2014-02-13	No	4	M	Direct
8,408	2016-02-13	No	4	M	Direct

Footnotes

The sale reported above was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 03/09/2011.
The sale price reported reflects the weighted average sale price of multiple transactions on the reported date at prices that ranged from $77.00 to $77.56, inclusive. The reporting person hereby undertakes to provide upon request to SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range.
Grant of options to buy shares of common stock becomes exercisable as to 4,400 shares on 02/03/2006, 02/03/2007, 02/03/2008, 02/03/2009, and the remaining 912 shares on 02/03/2010.
Grant of options to buy shares of common stock that vest on the fifth anniversary date (02/14/2011) of the grant.
Grant of options to buy shares of common stock becomes exercisable as to 218 shares on 02/14/2011, and the remaining 2,384 shares on 02/14/2012.
Grant of options to buy shares of common stock becomes exercisable as to 4,088 shares on 02/14/2008, 02/14/2009, 02/14/2010, 3,870 shares on 02/14/2011, and the remaining 1,704 shares on 02/14/2012.
Grant of options to buy shares of common stock becomes exercisable as to 3,772 shares on 02/14/2010, 02/14/2013, 3,773 shares on 02/14/2011, 02/14/2012, and the remaining 863 shares on 02/14/2014.